DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 165.51 USD 0.83% Market Closed
Market Cap: 13.6B USD
Have any thoughts about
DaVita Inc?
Write Note

Intrinsic Value

The intrinsic value of one DVA stock under the Base Case scenario is 226.71 USD. Compared to the current market price of 165.51 USD, DaVita Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DVA Intrinsic Value
226.71 USD
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
DaVita Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DVA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about DaVita Inc

Provide an overview of the primary business activities
of DaVita Inc.

What unique competitive advantages
does DaVita Inc hold over its rivals?

What risks and challenges
does DaVita Inc face in the near future?

Has there been any significant insider trading activity
in DaVita Inc recently?

Summarize the latest earnings call
of DaVita Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DaVita Inc.

Provide P/S
for DaVita Inc.

Provide P/E
for DaVita Inc.

Provide P/OCF
for DaVita Inc.

Provide P/FCFE
for DaVita Inc.

Provide P/B
for DaVita Inc.

Provide EV/S
for DaVita Inc.

Provide EV/GP
for DaVita Inc.

Provide EV/EBITDA
for DaVita Inc.

Provide EV/EBIT
for DaVita Inc.

Provide EV/OCF
for DaVita Inc.

Provide EV/FCFF
for DaVita Inc.

Provide EV/IC
for DaVita Inc.

Show me price targets
for DaVita Inc made by professional analysts.

What are the Revenue projections
for DaVita Inc?

How accurate were the past Revenue estimates
for DaVita Inc?

What are the Net Income projections
for DaVita Inc?

How accurate were the past Net Income estimates
for DaVita Inc?

What are the EPS projections
for DaVita Inc?

How accurate were the past EPS estimates
for DaVita Inc?

What are the EBIT projections
for DaVita Inc?

How accurate were the past EBIT estimates
for DaVita Inc?

Compare the revenue forecasts
for DaVita Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DaVita Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DaVita Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of DaVita Inc compared to its peers.

Compare the P/E ratios
of DaVita Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing DaVita Inc with its peers.

Analyze the financial leverage
of DaVita Inc compared to its main competitors.

Show all profitability ratios
for DaVita Inc.

Provide ROE
for DaVita Inc.

Provide ROA
for DaVita Inc.

Provide ROIC
for DaVita Inc.

Provide ROCE
for DaVita Inc.

Provide Gross Margin
for DaVita Inc.

Provide Operating Margin
for DaVita Inc.

Provide Net Margin
for DaVita Inc.

Provide FCF Margin
for DaVita Inc.

Show all solvency ratios
for DaVita Inc.

Provide D/E Ratio
for DaVita Inc.

Provide D/A Ratio
for DaVita Inc.

Provide Interest Coverage Ratio
for DaVita Inc.

Provide Altman Z-Score Ratio
for DaVita Inc.

Provide Quick Ratio
for DaVita Inc.

Provide Current Ratio
for DaVita Inc.

Provide Cash Ratio
for DaVita Inc.

What is the historical Revenue growth
over the last 5 years for DaVita Inc?

What is the historical Net Income growth
over the last 5 years for DaVita Inc?

What is the current Free Cash Flow
of DaVita Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for DaVita Inc.

Business Breakdown

DaVita Inc. has emerged as a leading healthcare provider specializing in kidney care, operating over 2,800 outpatient dialysis centers across the United States and 10 additional countries. Founded in 1994, the company has made significant strides in enhancing the quality of life for individuals battling chronic kidney disease. With a mission deeply rooted in patient care, DaVita focuses on delivering comprehensive treatment and support, ensuring that patients receive not only dialysis services but also vital education and resources for managing their condition. This commitment to patient-centric care has positioned DaVita as a notable player in the burgeoning healthcare sector, making it an...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DaVita Inc

Current Assets 4B
Cash & Short-Term Investments 1.1B
Receivables 2.6B
Other Current Assets 313.9m
Non-Current Assets 13.5B
Long-Term Investments 464.3m
PP&E 5.4B
Intangibles 7.4B
Other Non-Current Assets 219m
Current Liabilities 2.9B
Accounts Payable 488.2m
Accrued Liabilities 1.2B
Other Current Liabilities 1.2B
Non-Current Liabilities 14.2B
Long-Term Debt 9.3B
Other Non-Current Liabilities 4.9B
Efficiency

Earnings Waterfall
DaVita Inc

Revenue
12.7B USD
Cost of Revenue
-8.5B USD
Gross Profit
4.2B USD
Operating Expenses
-2.3B USD
Operating Income
1.9B USD
Other Expenses
-1.1B USD
Net Income
827.7m USD

Free Cash Flow Analysis
DaVita Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the third quarter, DaVita reported an adjusted operating income of $535 million and earnings per share of $2.59, indicating stability despite challenges like hurricanes impacting treatment volume and supply disruptions. The company projects revenue growth per treatment to remain between 3.5% and 4%, and confirmed 2024 adjusted operating income guidance of $1.91 billion to $2.01 billion. Although headwinds persist, notably from elevated mortality and supply chain issues, DaVita's strong operational performance and disciplined capital strategies position them favorably for continued growth, including a full-year treatment volume increase of 0.5% to 1%.

What is Earnings Call?
Fundamental Scores

DVA Profitability Score
Profitability Due Diligence

DaVita Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
ROE is Increasing
Positive Gross Profit
65/100
Profitability
Score

DaVita Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

DVA Solvency Score
Solvency Due Diligence

DaVita Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
Positive Net Debt
36/100
Solvency
Score

DaVita Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DVA Price Targets Summary
DaVita Inc

Wall Street analysts forecast DVA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVA is 162.96 USD with a low forecast of 138.49 USD and a high forecast of 195.3 USD.

Lowest
Price Target
138.49 USD
16% Downside
Average
Price Target
162.96 USD
2% Downside
Highest
Price Target
195.3 USD
18% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DVA?

Click here to dive deeper.

Dividends

DaVita Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DVA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DVA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

DVA News

Other Videos

Profile

DaVita Inc Logo
DaVita Inc

Country

United States of America

Industry

Health Care

Market Cap

13.7B USD

Dividend Yield

0%

Description

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 69,000 full-time employees. The firm's principal business is to provide dialysis and related lab services to patients. The company is engaged in providing care delivery, referred to as United States (U.S.) dialysis business. The firm also operate various ancillary services, including its international operations, as well as its corporate administrative support. Its U.S. dialysis business is a provider of kidney dialysis services for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD). The firm's ancillary services consist primarily of integrated care and disease management, clinical research programs and physician services, as well as its international operations. The firm's international dialysis operations provides dialysis and administrative services through a total of 333 outpatient dialysis centers located in ten countries outside of the United States.

Contact

COLORADO
Denver
2000 16th St
+13105362668.0
www.davita.com

IPO

1995-10-31

Employees

69 000

Officers

CEO & Executive Director
Mr. Javier J. Rodriguez
CFO & Treasurer
Mr. Joel Ackerman
Chief Legal & Public Affairs Officer
Ms. Kathleen Alyce Waters
Chief Compliance Officer
Mr. James O. Hearty
Chief Operating Officer
Mr. David Maughan
Group VP & Chief Accounting Officer
Mr. Christopher Michael Berry
Show More
Chief Information Officer
Ms. Madhu Narasimhan
Group Vice President of Investor Relations
Nic Eliason
Chief People Officer
Ms. Jessica Hergenreter
Chief Transformation Officer of U.S. Kidney Care Business
Mr. Misha Palecek
Show Less

See Also

Discover More
What is the Intrinsic Value of one DVA stock?

The intrinsic value of one DVA stock under the Base Case scenario is 226.71 USD.

Is DVA stock undervalued or overvalued?

Compared to the current market price of 165.51 USD, DaVita Inc is Undervalued by 27%.

Back to Top